| Year |
Citation |
Score |
| 2002 |
Gilmor ML, Owens MJ, Nemeroff CB. Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. The American Journal of Psychiatry. 159: 1702-10. PMID 12359676 DOI: 10.1176/appi.ajp.159.10.1702 |
0.437 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2003 |
Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. The Journal of Pharmacology and Experimental Therapeutics. 305: 434-9. PMID 12606697 DOI: 10.1124/jpet.102.045419 |
0.25 |
|
| 2007 |
Robinson DS, Gilmor ML, Yang Y, Moonsammy G, Azzaro AJ, Oren DA, Campbell BJ. Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials. Psychopharmacology Bulletin. 40: 15-28. PMID 18007565 |
0.241 |
|
| 1996 |
Gilmor ML, Nash NR, Roghani A, Edwards RH, Yi H, Hersch SM, Levey AI. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 2179-90. PMID 8601799 DOI: 10.1523/Jneurosci.16-07-02179.1996 |
0.2 |
|
| 1998 |
Gilmor ML, Counts SE, Wiley RG, Levey AI. Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesions. Journal of Neurochemistry. 71: 2411-20. PMID 9832139 DOI: 10.1046/J.1471-4159.1998.71062411.X |
0.185 |
|
| 2001 |
Gilmor M, Heilman C, Nash N, Levey A. UNIT 5.7 Production of Antisera Using Fusion Proteins Current Protocols in Protein Science. DOI: 10.1002/0471142301.Ns0507S00 |
0.184 |
|
| 2000 |
Rouse ST, Edmunds SM, Yi H, Gilmor ML, Levey AI. Localization of M(2) muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus. Neuroscience Letters. 284: 182-6. PMID 10773429 DOI: 10.1016/S0304-3940(00)01011-9 |
0.167 |
|
| 1999 |
Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. The Journal of Comparative Neurology. 411: 693-704. PMID 10421878 DOI: 10.1002/(Sici)1096-9861(19990906)411:4<693::Aid-Cne13>3.0.Co;2-D |
0.162 |
|
| 2002 |
Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. The Journal of Comparative Neurology. 443: 136-53. PMID 11793352 DOI: 10.1002/Cne.10122 |
0.16 |
|
| 2000 |
Cho GW, Kim MH, Chai YG, Gilmor ML, Levey AI, Hersh LB. Phosphorylation of the rat vesicular acetylcholine transporter. The Journal of Biological Chemistry. 275: 19942-8. PMID 10748073 DOI: 10.1074/Jbc.M902174199 |
0.136 |
|
| 2007 |
Blob LF, Sharoky M, Campbell BJ, Kemper EM, Gilmor MG, VanDenberg CM, Azzaro AJ. Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour. Cns Spectrums. 12: 25-34. PMID 17192761 |
0.131 |
|
| 2015 |
Fowler JS, Logan J, Volkow ND, Shumay E, McCall-Perez F, Jayne M, Wang GJ, Alexoff DL, Apelskog-Torres K, Hubbard B, Carter P, King P, Fahn S, Gilmor M, Telang F, et al. Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 650-7. PMID 25249059 DOI: 10.1038/Npp.2014.214 |
0.127 |
|
| 1998 |
Rouse ST, Gilmor ML, Levey AI. Differential presynaptic and postsynaptic expression of m1-m4 muscarinic acetylcholine receptors at the perforant pathway/granule cell synapse. Neuroscience. 86: 221-32. PMID 9692756 DOI: 10.1016/S0306-4522(97)00681-7 |
0.104 |
|
| 1998 |
Miller GW, Gilmor ML, Levey AI. Generation of transporter-specific antibodies. Methods in Enzymology. 296: 407-22. PMID 9779463 DOI: 10.1016/S0076-6879(98)96029-3 |
0.091 |
|
| 2003 |
Gilmor MI, Wong AF. Seismic design provisions of CSA S16-01 limit states design of steel structures Proceedings, Annual Conference - Canadian Society For Civil Engineering. 2003: 1426-1435. |
0.01 |
|
| 2001 |
Roy M, Gilmor MI. Detailer training in Canada Modern Steel Construction. 41: 68. |
0.01 |
|
| 2000 |
Gilmor MI. CSA S16, the steel standard for the 21st century 2000 Annual Conference Abstracts - Canadian Society For Civil Engineering. 175. |
0.01 |
|
| 1977 |
Firmin A, Gilmor MI, Collins RA. COMPUTER PROGRAMS FOR STRUCTURAL ANALYSIS AND DESIGN - A CANADIAN VIEW. Canadian Journal of Civil Engineering. 4: 72-85. |
0.01 |
|
| Hide low-probability matches. |